株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

デジタル療法 (Digital Therapeutics) の米国市場の予測:~2023年

US Digital Therapeutics Market, Forecast to 2023

発行 Frost & Sullivan 商品コード 648619
出版日 ページ情報 英文 143 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.24円で換算しております。
Back to Top
デジタル療法 (Digital Therapeutics) の米国市場の予測:~2023年 US Digital Therapeutics Market, Forecast to 2023
出版日: 2018年05月25日 ページ情報: 英文 143 Pages
概要

デジタル療法 (Digital Therapeutics) の市場は予測期間中、30.7%のCAGR (年間複合成長率) で成長すると予測されています。

当レポートでは、米国のデジタル療法 (Digital Therapeutics) の市場を調査し、市場の定義と概要、エコシステム、ビジネスモデル、部門別の収益規模の推移と予測、技術動向とロードマップ、競合環境、主要参入企業のプロファイル、成功戦略・成長機会の分析、将来の展望などをまとめています。

第1章 エグゼクティブサマリー

第2章 デジタル療法市場:確実視される機会の定義

  • デジタルヘルスの市場区分
  • デジタル療法の起源
  • デジタル療法
  • 主な定義
  • デジタルヘルスにおけるデジタル療法の位置付け
  • mヘルスともデジタルヘルスとも異なるデジタル療法
  • デジタル療法に関心を寄せる医薬品企業
  • デジタル療法と医薬品企業
  • デジタルヘルス:mヘルスからの進化
  • 様々な因子に推進されるmヘルス市場
  • デジタル療法:技術動向とロードマップ、など

第3章 初期のデジタル療法の市場

  • 市場区分
  • 分類
  • デジタル療法・進歩の領域
  • デジタル療法アライアンス
  • FDAのPreCert(Digital Health Software Precertification)プログラム

第4章 市場予測・市場動向

  • マーケットエンジニアリング測定
  • 予測前提因子
  • ピュアプレイデジタル療法市場:収益予測
  • ピュアプレイデジタル療法市場:収益予測に関するディスカッション
  • 総市場市場:収益予測
  • 総市場市場:収益予測に関するディスカッション
  • 総市場市場:収益予測:部門別
  • 総市場市場:収益シェア:部門別
  • 総市場市場:収益シェア予測:部門別
  • 慢性症状管理部門:収益予測
  • 慢性症状管理部門:収益予測に関するディスカッション
  • 行動管理部門:収益予測
  • 行動管理部門:収益予測に関するディスカッション
  • 服薬遵守支援部門:収益予測
  • 服薬遵守支援部門:収益予測に関するディスカッション
  • データ収集&アナリティクス部門:収益予測
  • データ収集&アナリティクス部門:収益予測に関するディスカッション

第5章 競合環境

  • 競合市場構造
  • 競合力学
  • デジタル療法のエコシステム
  • デジタル療法:現在のバイヤーと潜在バイヤー
  • ビジネスモデル
  • プロフェッショナル-顧客スペクトラム
  • ベンダーエコシステム

第6章 デジタル療法のピュアプレイ企業

  • Pear Therapeutics
  • WellDoc
  • Chrono Therapeutics
  • Omada Health
  • Proteus Digital Health
  • Noom Inc.
  • MySugr (Roche Diabetes Care)
  • Click Therapeutics
  • Canary Health
  • CellScope
  • Virta Health

第7章 隣接市場の参入企業

  • AliveCor
  • Apple, Inc.
  • Oscar Health Insurance Corporation
  • Big Health Ltd. (Sleepio)

第8章 デジタルサービス&デバイス企業

  • 医療機器企業とデジタル療法
  • ライフスタイルサービス企業とデジタル療法
  • 保険者とデジタル療法
  • デジタルメディシン投資ポートフォリオ

第9章 他の参入企業:デジタル療法イニシアチブ

第10章 成長機会

  • 将来の戦略・重要な成長機会
  • 成長レバー
  • 成長機会:デジタル療法の定義
  • 成長機会:デジタル療法の認知度向上
  • 成長機会:ビジネスモデルの構築
  • 成長機会:より多くの症状に向けたソリューションの開発
  • 成長機会:データの強化
  • 戦略的必須要件

第11章 将来の展望

  • 技術:デジタル療法への影響
  • 三大予測

第12章 付録

第13章 FROST & SULLIVANについて

目次
Product Code: K270-48

Many New Services Evolving from Digital Health and mHealth are Expected to Drive Growth, Reduce Healthcare Costs, and Improve Patient Outcomes

Digital therapeutics are about to become a true medical alternative that will utilize communications-based technologies, apps, and software to improve patient outcomes and help to lower the cost of healthcare. The overall digital therapeutics market is expected to grow at a compound annual growth rate of 30.7% from 2017 to 2023.

This report emphasizes the importance of clearly defining the term "digital therapeutics." In many areas of the evolving healthcare market, an important facet of understanding opportunity and strategy is effective definition and scoping of new terminology and concepts. Frost & Sullivan reviews data that illustrate there is often an inconsistent definition of the term as well as the companies that are participating in this early market. The research reveals that there is a much smaller segment of the digital therapeutics market devoted to pure play participants that are developing true therapeutic solutions that will provide a medical-grade benefit to patients. The pure play market will require considerable research and development in partnership with pharmaceutical companies, and a US Food and Drug Administration certification for safety and efficacy after a clinical trial.

Frost & Sullivan predicts that the digital therapeutics market will attract the interests of medical device companies, pharmaceutical industry participants, and investors. It is reasonable to foresee that several of the larger, established healthcare companies will carefully monitor progress in this space and make strategic moves as the smaller, new entrants demonstrate successful outcomes following randomized clinical trials.

Research Scope:

The objective of this research service is to present an analysis of the US digital therapeutics market with respect to key market dynamics at play through 2023 and showcase select areas of opportunity in a landscape of related segments. The study describes and defines the digital therapeutics market and enabling technology; covers factors driving the need to deploy this emerging solution to enable improved patient outcome-based drug replacement, drug augmentation, and interactive communications platforms across a variety of specialties; examines challenges impacting the market; presents an outlook for the adoption of digital therapeutic services among key customer segments; presents Frost & Sullivan forecasts for overall market growth; and looks at opportunities in the total market and key market segments as estimated for the forecast period.

Key Issues Addressed:

  • What are pure play digital therapeutic services, and how are these solutions being deployed to patients, healthcare payers, employer plans, hospitals and physicians?
  • What are the market-shifting macro trends affecting the need to deploy new digital therapeutic solutions to enable patients to achieve quality care in a variety of settings?
  • What companies have a presence in the digital therapeutics market, either as pure play participants or within the wider view of the market?
  • What are the segments of the digital therapeutics and digital health-related market, and which ones offer the best opportunities for growth?
  • What is the 6-year revenue outlook for the digital therapeutics market and the major segments?

Table of Contents

1. EXECUTIVE SUMMARY

  • Key Findings
  • Key Findings (continued)
  • Key Findings (continued)
  • Key Findings (continued)
  • Scope and Segmentation
  • Key Questions This Study Will Answer
  • Market Engineering Measurements
  • CEO's Perspective
  • 3 Big Predictions

2. DIGITAL THERAPEUTICS MARKET-DEFINING A PROMISING OPPORTUNITY

  • Digital Health Market Segmentation
  • Digital Therapeutics Origin
  • Digital Therapeutics
  • Key Definitions
  • Digital Therapeutics' Position in Digital Health
  • Digital Therapeutics is Neither mHealth nor Digital Health
  • Pharma is Increasingly Interested in Digital Therapeutics
  • Digital Therapeutics and Pharmaceutical Companies
  • Digital Health Is Evolving from mHealth
  • mHealth Market Has Been Driven by Various Forces
  • Digital Health-Highest Impact Segments on Healthcare
  • Foundation for Digital Health and Therapeutics
  • Digital Therapeutics Technology Trends and Roadmap

3. THE EARLY DIGITAL THERAPEUTICS MARKET

  • Market Segmentation
  • Breaking Down the Segments
  • Digital Therapeutics and Health Areas of Progress
  • Digital Therapeutics Alliance
  • FDA Digital Health Software Precertification Program

4. FORECASTS AND TRENDS-TOTAL MARKET AND SEGMENT ANALYSIS

  • Market Engineering Measurements
  • Forecast Assumptions and Considerations
  • Full-Scale Market and Pure Play Solution Attributes
  • Pure Play Digital Therapeutics Market-Revenue Forecast
  • Pure Play Digital Therapeutics Market-Revenue Forecast Discussion
  • Total Digital Therapeutics Market-Revenue Forecast
  • Total Digital Therapeutics Market-Revenue Forecast Discussion
  • Total Digital Therapeutics Market-Revenue Forecast by Segment
  • Total Digital Therapeutics Market-Revenue Share by Segment
  • Total Digital Therapeutics Market-Revenue Share Forecast by Segment
  • Chronic Condition Management Segment-Revenue Forecast
  • Chronic Condition Management Segment-Revenue Forecast Discussion
  • Behavior Management Segment-Revenue Forecast
  • Behavior Management Segment-Revenue Forecast Discussion
  • Medication Adherence Support Segment-Revenue Forecast
  • Medication Adherence Support Segment-Revenue Forecast Discussion
  • Data Gathering and Analytics Segment-Revenue Forecast
  • Data Gathering and Analytics Segment-Revenue Forecast Discussion

5. COMPETITIVE ENVIRONMENT

  • Competitive Market Structure
  • Competitive Dynamics
  • The Digital Therapeutics Ecosystem-Technologies Add Value to Traditional Prescription-Based Treatments
  • Digital Therapeutics-Current and Potential Buyers
  • Business Models in Digital Therapeutics
  • Professional-Consumer Spectrum
  • Vendor Ecosystem

6. PURE PLAY DIGITAL THERAPEUTICS COMPANIES

  • Pear Therapeutics
  • WellDoc
  • Chrono Therapeutics
  • Omada Health
  • Proteus Digital Health
  • Noom Inc.
  • MySugr (Roche Diabetes Care)
  • Click Therapeutics
  • Canary Health
  • CellScope
  • Virta Health

7. ADJACENT MARKET PARTICIPANTS

  • AliveCor
  • Apple, Inc.
  • Oscar Health Insurance Corporation
  • Big Health Ltd. (Sleepio)

8. DIGITAL SERVICES AND DEVICE COMPANIES

  • Medical Device Companies and Digital Therapeutics
  • Medical Device Companies and Digital Therapeutics (continued)
  • Lifestyle Services Companies and Digital Therapeutics
  • Payer Focused on Digital Therapeutics
  • Digital Medicine Investment Portfolio

9. ADDITIONAL MARKET ENTRANTS-DIGITAL THERAPEUTICS INITIATIVES

  • Additional Digital Therapeutics Companies
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)

10. GROWTH OPPORTUNITIES

  • 5 Growth Opportunities Critical for Future Strategies
  • Levers for Growth
  • Growth Opportunity 1-Define Digital Therapeutics
  • Growth Opportunity 2-Increase Awareness of Digital Therapeutics
  • Growth Opportunity 3-Develop Business Models
  • Growth Opportunity 4-Develop Solutions for More Conditions
  • Growth Opportunity 5-Harness the Data
  • Strategic Imperatives for Digital Therapeutics

11. FUTURE PERSPECTIVES

  • Technology-Future Impact on Digital Therapeutics
  • 3 Big Predictions
  • Legal Disclaimer

12. APPENDIX

  • List of Exhibits
  • List of Exhibits (continued)
  • Additional Frost & Sullivan Coverage of Telehealth
  • Selected Sources
  • Selected Sources (continued)
  • Selected Sources (continued)

13. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top